Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (261-270 of 361) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Detection of NRG1 Gene Fusions in Solid TumorsSushma Jonna, Rebecca A Feldman, Jeffrey Swensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug AdministrationG Mountzios, J Remon, S Novello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trialBarbara J Gitlitz, Denice D Tsao-Wei, Susan Groshen, et al.
Expert Review of Anticancer Therapy|April 16, 2025
Prevalence and molecular correlates of acquired <i>EGFR</i> resistance mutations in non-small cell lung cancer (NSCLC)Luis E Raez, Yasmine Baca, Jennifer R Ribeiro, et al.
Nature|July 23, 2013
Elucidation of the Fe(IV)=O intermediate in the catalytic cycle of the halogenase SyrB2Shaun D Wong, Martin Srnec, Megan L Matthews, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
Virology|June 19, 2017
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferretsGale E Smith, Xiangjie Sun, Yaohui Bai, et al.
Pageof 37

Showing results (261-270 of 361) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Detection of NRG1 Gene Fusions in Solid TumorsSushma Jonna, Rebecca A Feldman, Jeffrey Swensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug AdministrationG Mountzios, J Remon, S Novello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trialBarbara J Gitlitz, Denice D Tsao-Wei, Susan Groshen, et al.
Expert Review of Anticancer Therapy|April 16, 2025
Prevalence and molecular correlates of acquired <i>EGFR</i> resistance mutations in non-small cell lung cancer (NSCLC)Luis E Raez, Yasmine Baca, Jennifer R Ribeiro, et al.
Nature|July 23, 2013
Elucidation of the Fe(IV)=O intermediate in the catalytic cycle of the halogenase SyrB2Shaun D Wong, Martin Srnec, Megan L Matthews, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Development, Review, and Activation of Thoracic Oncology Investigator-Initiated TrialsDavid E Gerber, Claire R Wynters, Tanushree Prasad, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
Virology|June 19, 2017
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferretsGale E Smith, Xiangjie Sun, Yaohui Bai, et al.
Pageof 37